Health Care: Drugs

ACADIA Pharmaceuticals Inc (ACAD: NASDAQ)

$28.26 n/a | n/a%
06/28/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 28.26
52 Week High 40.83
52 Week Low 20.68
Avg. Daily Vol. (Mil) 1.53
Beta (3 year) 4.54
Share Related Items
Mkt Cap (Mil) 3,449.03
Shares Out (Mil) 122.05
Float (Mil) 77.64
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 10.60
Current Ratio 10.80
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 105.76
Price/Book 7.54
Price/Cash Flow -11.20
Per Share Data
Earnings -2.61
Sales 0.27
Book Value 3.75
Cash Flow -2.51
Business Summary
ACADIA Pharmaceuticals Inc is a biotechnology company which develops and commercializes biopharmaceutical products to address central nervous system disorders. It aims to discover small molecule drugs to address Parkinson's, Alzheimer's and schizophrenia.
General Information
3611 Valley Centre Drive
Suite 300
San Diego, CA 92130
www.acadia-pharm.com
Industry : Drugs
Sector: Health Care
Employees: 400
CEO: Mr. Stephen R. Davis
Short Interest
Current Month (Mil) 19.06
Previous Month (Mil) 19.55
Short Interest Ratio (Days) 12.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -61.50
Return on Investments -67.60
Profitability
Gross Margin 91.40
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ACAD

Latest ACAD Headlines from TheStreet

More Financial News for ACAD

Press Releases for ACAD

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter